Warning: fopen(includes/rss-cache/amazon-Books-Cancer) [function.fopen]: failed to open stream: No such file or directory in /home/jen1527/public_html/stage4cancersite.com/includes/amazon.php on line 984
Warning: fwrite(): supplied argument is not a valid stream resource in /home/jen1527/public_html/stage4cancersite.com/includes/amazon.php on line 985
Warning: fclose(): supplied argument is not a valid stream resource in /home/jen1527/public_html/stage4cancersite.com/includes/amazon.php on line 986
Epidemiology: Non-Small Cell Lung Cancer - Despite Global Efforts to Stop Smoking, Incidence Rates will Remain Unchanged
NEW YORK , Jan. 17, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Epidemiology: Non-Small Cell Lung Cancer – Despite global efforts to ...
Investigators have defined the role of a recently identified gene abnormality – rearrangements in the ROS1 gene – in a deadly form of lung cancer. ROS1-rearranged tumors represent one to two percent of non-small-cell lung cancers, the leading cause of cancer death in the US. The researchers also show that ROS1-driven tumors can be treated with crizotinib and describe the remarkable response of ...
Massachusetts General study defines a new genetic subtype of lung cancer
( Massachusetts General Hospital ) Investigators at the Massachusetts General Hospital Cancer Center have defined the role of a recently identified gene abnormality - rearrangements in the ROS1 gene - in a deadly form of lung cancer. ROS1-rearranged tumors represent one to two percent of non-small-cell lung cancers, the leading cause of cancer death in the US. The researchers also show that ROS1 ...
( University of Colorado Denver ) Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase positive advanced non-small cell lung cancer becomes resistant to a drug targeting the abnormal protein in the cancer. It's the first time scientists have analyzed the frequency ...
Study defines a new genetic subtype of lung cancer
A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ROS1 gene represent 1 to 2 percent of non-small-cell lung cancers (NSCLC), the leading cause of cancer death in the U.S. The researchers show that ROS1-driven tumors can be ...